Gessel has advised Polski Bank Komorek Macierzystych on its acquisition of 70% shares in the newly created Famicord-Acibadem company. Caliskan Okkan Tokker reportedly advised PBKM as well, while Esin Attorney Partnership advised Acibadem on the transaction.
PBKM is the largest stem cell bank in Poland, and it leads the international FamiCord Group, which manages stem cell banks located in Europe and Turkey.
The Acibadem Health Group, which was founded in 1991 and is a private health institution in Turkey, operates 21 hospitals and 13 clinics in four countries.
Gessel’s team included Partner Maciej Kozuchowski and Senior Lawyer Piotr Rysiak.
Esin Attorney Partnership's team included Partner Caner Elmas and Associates Sila Pinar and Defne Sahin.
